{'text': 'Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues', 'publisher': {'href': 'https://www.fiercebiotech.com', 'title': 'Fierce Biotech'}, 'created_at': 'Tue, 20 Aug 2024 10:43:55 GMT', 'description': 'Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues  Fierce Biotech', 'url': 'https://news.google.com/rss/articles/CBMiugFBVV95cUxPT1k3SUVXdER5TjlfYzhrdUhmN2N0SldybXI4cEc4TGp6NW9OT3l2NjRRbkZBelBFRnRXQ3IxN212WVRzaWc5ZnphSEZDZzBrd2FfUGVDMzZrcGpNWEhtRTgwRjhNYnRSN1RhaHdJRThfY0dyWEUzU2JNbFBwNU1aOTFNN2VtYjA4OHhuX2p6aHZuM0JFU0g4bGVMVW5LSTNfQXNLMjBaTW9jaUkzT0ZpR2p6cTFxWkVGaUE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Is Merck Stock A Better Pick Over AbbVie?', 'publisher': {'href': 'https://www.forbes.com', 'title': 'Forbes'}, 'created_at': 'Wed, 21 Aug 2024 09:00:02 GMT', 'description': 'Is Merck Stock A Better Pick Over AbbVie?  Forbes', 'url': 'https://news.google.com/rss/articles/CBMioAFBVV95cUxPM3JnWWlQVnZvTFltcUxYdjZPM1hMcUhxazlLT0tuYUhpUGZab0paNzZwR2xhV28zdHkxOGgxdDlUQ3BQVU5fczc2bE90NkVlU1psaHNNdnJqQnZwZmxuWEJ2dWgzTExzQzFMcHRvcEtLbFBFakJqM25udmhaZkgwdnFXY25pZlZzUEo5YW9iTWlfbHJqR1N1YUhlLWFCOV9Z?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "First real-world analysis of Merck's Ebola vaccine reveals 84% effectiveness during DRC outbreak", 'publisher': {'href': 'https://www.fiercepharma.com', 'title': 'FiercePharma'}, 'created_at': 'Thu, 22 Aug 2024 11:50:00 GMT', 'description': "First real-world analysis of Merck's Ebola vaccine reveals 84% effectiveness during DRC outbreak  FiercePharma", 'url': 'https://news.google.com/rss/articles/CBMixwFBVV95cUxOVG0xTHFBdmxFU2lsQldTV1JKS1ItS2Jzb1BlUk85MkNxQ1ZiVF9VbGM2TWVvc29nZzB2RVFfTnk3OFdzOWpJSWRaNUdjVTV5VS1yeVd2WHV3VENZcWtKS245MmdwQ1pUWGpjUElTOWtNN1JZM2tfMHhET2s3c1Y5WHNtNnpDSEMySHhVZ2hQS1JHUnAzcWFmdWw5czAtMzBOeWhGZ3NtZm41WkhyZWh3bnY5V1M5aHZTOFcwV0w4Ty1XSUZ4Tm8w?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck Ebola vaccine Ervebo shown to offer substantial protection', 'publisher': {'href': 'https://www.statnews.com', 'title': 'STAT'}, 'created_at': 'Wed, 21 Aug 2024 17:47:07 GMT', 'description': 'Merck Ebola vaccine Ervebo shown to offer substantial protection  STAT', 'url': 'https://news.google.com/rss/articles/CBMitAFBVV95cUxQWlZveDFhbGhfejlEQ0NZWlZWLUFpN25xU1JWMUU0SERjRXVCSkEwQXpSTEZFWVNrdkZDWWppYmZ1d3BVN1JlUGZTNmtJVy15eUczNUplUmd6MC1lVkExd3UyVkY3Y2hfQkNkQVBuODQ1ZndneHhyZUVMTE0zOWpJaWtNeUlxV0c2WWxRUzFXZUlXNGVUX1BEMzdkNW92NTE2dVR0V1RyOHoxeFJLZWtRTUJ1S1k?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck Insiders Sell US$11m Of Stock, Possibly Signalling Caution', 'publisher': {'href': 'https://finance.yahoo.com', 'title': 'Yahoo Finance'}, 'created_at': 'Tue, 20 Aug 2024 14:00:08 GMT', 'description': 'Merck Insiders Sell US$11m Of Stock, Possibly Signalling Caution  Yahoo Finance', 'url': 'https://news.google.com/rss/articles/CBMifEFVX3lxTE02THh3c3RtWmJJa0cwLU5uUmFNM2pEaFBjU2Jqd1N2SjJOMFpNLWVJbTRuUnRIdkxpNUZLTnloVWE5ZzQyVnZfNTlWWkQwdWdSVmlXRkFhWWVMbVNhQVlBNkdSMzQ0UFk2YnRPUHN1NkwyOWlDUEZvZGYxNjE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Jim Cramer Says He Has ‘Tremendous Faith’ Merck (MRK) CEO', 'publisher': {'href': 'https://finance.yahoo.com', 'title': 'Yahoo Finance'}, 'created_at': 'Wed, 21 Aug 2024 13:29:09 GMT', 'description': 'Jim Cramer Says He Has ‘Tremendous Faith’ Merck (MRK) CEO  Yahoo Finance', 'url': 'https://news.google.com/rss/articles/CBMihAFBVV95cUxOTzdLM0cxSWNyTkU1YXdyRlFQX1NvdUU2YVRJR3RDUXRXX3gyNzBGMXIwWm1mdlJTYVJrSWRDc2FsQzhOZ1VYTVBhSEs0bnN2aTE1T0hzRk1rZm81ZUFOWG9EdXZzMzVpWWxKQ3VJeDBLT2NGYWFXWjg3QjIzZzVlOTQzcXA?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds', 'publisher': {'href': 'https://www.fiercepharma.com', 'title': 'FiercePharma'}, 'created_at': 'Thu, 22 Aug 2024 19:28:09 GMT', 'description': 'FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds  FiercePharma', 'url': 'https://news.google.com/rss/articles/CBMitAFBVV95cUxOSDhTRWdERXhldVFIOGU4elBJMWpiaVFZUmR4LVZfNVE3VDg3ZVlaSl9tZ3Rqc1pzYkZycEN1aDVaZ2ppY29UZXBBSXQzbkFEcmdMRFZWSkRGLW85eUJQYThHSjVCT1p0TFpXYzdxaUhNNWVzb0VOUFlqSDRaRmdZUktrNUFpT2M4N1Z2UXdYSGoxVmRXT3YxRnV1ZVNhS3VDYnBZWUxCbThkUmZTV3lfU2RMd1o?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda', 'publisher': {'href': 'https://www.cnbc.com', 'title': 'CNBC'}, 'created_at': 'Tue, 30 Jul 2024 07:00:00 GMT', 'description': 'Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda  CNBC', 'url': 'https://news.google.com/rss/articles/CBMicEFVX3lxTE5WU3I1UnBkNG43elhaZVlZaGxKQXZMSVM1ZE1ReXJhbE82SUI4MzhrTlZ0ekw1Q0lhUG1SYVFyZW92ZkdNRkNvU3BtQ0Nkd3VETEdIOHVaSFF0VVd0MWxYd3loNGtUVDBNdWVwalV3YjXSAXZBVV95cUxNQTlCOENUTGo5R2w4MlZyOWhNczh6UTExU3YySEJBWXVqN3Z2aFNXbU8zbGoxWFlXVnNfWHFBZ0hyemlzanJqY1dQNkNLWmxSTEFNbjlTaU4wbTI0RUU4Smo5RW1GNThmQjZLMkZhQS1HMGI5R0V3?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Merck's RSV shot helps protect infants in mid-to-late stage study", 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Tue, 23 Jul 2024 07:00:00 GMT', 'description': "Merck's RSV shot helps protect infants in mid-to-late stage study  Reuters", 'url': 'https://news.google.com/rss/articles/CBMixwFBVV95cUxOUVZlRldJeXNfeFVlSERZWlRXVng0Nm82NjJUNDVfS3luc0F4VndEU1U4TzktcFFldEZtMHRpRGVLV3QxREVtRlZESWRFNUxuY0JZQTRuQktiSWxJWEp2Q09pOWRHbGV3SjB0NEtobldmT2xMbHlkTUhXSzhNMXpJekdiVy1pTUY2WTk3ekpuRjYybG9PV0lnWjF2dUZkTjB6cFdSVHVRVUJ4RUhYelc5MDhaLTY1ZlVnaXc1LXFudkhSd0dScWV3?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck lays off workers amid rough pharma job market', 'publisher': {'href': 'https://www.statnews.com', 'title': 'STAT'}, 'created_at': 'Wed, 24 Jul 2024 07:00:00 GMT', 'description': 'Merck lays off workers amid rough pharma job market  STAT', 'url': 'https://news.google.com/rss/articles/CBMitgFBVV95cUxNZW9GMGRrSEc0RGdRS3ZwRnpwRTdUMXVKYktnMGlxUGpUZ202MTY1b2RDV0I2M2IyUjdvWTBwTEljcGtpMm5ndllqQ2NBV3Y0ZmlfbWJnR1Z1dGhnNEV1ZTJTeWtZdnp4ckw2TFRjeFVvUkdHNGxwUGhtbHA1TzFCRmxaNWVNcDVNZ01VZTgzMzgtbjg0ZnFyRjloVURrYzJqNUl1TGluT3RZQUJ2VEpoLXUwZ3A5Zw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Communicator spotlight: Cristal Downing, Merck's chief communications and public affairs officer", 'publisher': {'href': 'https://www.axios.com', 'title': 'Axios'}, 'created_at': 'Thu, 22 Aug 2024 16:56:26 GMT', 'description': "Communicator spotlight: Cristal Downing, Merck's chief communications and public affairs officer  Axios", 'url': 'https://news.google.com/rss/articles/CBMigwFBVV95cUxOWG1LZ3pON0otOV9YajJqUWxPeERwMTBiMDZFdjBVTUR3dGcwZjZZZ3VtNUxKWGkwZ1d6bDY2WS1VUjRuMk9FMTFpYmxCTFdHNEtJY2R1Q0tIbzdIVjB5dUQ0a3Bsc3dzYjR3WTZLNnZmMWpuaXV4N0RvMWxoekM5d2FWcw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck Plans to Acquire Investigational Bispecific Antibody from Curon Biopharmaceutical in $1.3 Billion Deal', 'publisher': {'href': 'https://www.biopharminternational.com', 'title': 'BioPharm International'}, 'created_at': 'Wed, 21 Aug 2024 17:15:24 GMT', 'description': 'Merck Plans to Acquire Investigational Bispecific Antibody from Curon Biopharmaceutical in $1.3 Billion Deal  BioPharm International', 'url': 'https://news.google.com/rss/articles/CBMi5AFBVV95cUxOZ21walFLRFVMLW5NYnRQSGlqNjlmNm5pQ045ZjFvU1I0QUdwbUphOFZrWFBGa0VZSjFCbUExaVVmQUxOc0hlR3hJcHBiRkltamIzRkxWdFloZzAyZ2NPMHhIUWlheWk3V1E5OU5scW5zblVNRlVQTWxSd1FqWC1JaEtQN1FFcEVjZFU2Y01vZ2lkamNKNVl3cUw5dGRFamdjS0V0OURKYTJ2N0Q1LXlIQk9nLVhmcHAyY0Ffa0lqZXhSU1U0VmY1OVk5ZXg4bWs1NzJPZnhpb25VVVVSellvWndwQy0?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck (MRK): Company Profile, Stock Price, News, Rankings', 'publisher': {'href': 'https://fortune.com', 'title': 'Fortune'}, 'created_at': 'Mon, 05 Aug 2024 07:00:00 GMT', 'description': 'Merck (MRK): Company Profile, Stock Price, News, Rankings  Fortune', 'url': 'https://news.google.com/rss/articles/CBMiSkFVX3lxTFBxX0ljWkpFS3QtQlNacUU5bm5FLTVlZFRnQzdQbnhVZXlHMzE1NVp4Y3Y2TllwcGJ6Vi0za0JJOXM3UDlpZE5UU0tB?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck & Co. Inc. stock outperforms competitors on strong trading day', 'publisher': {'href': 'https://www.marketwatch.com', 'title': 'MarketWatch'}, 'created_at': 'Tue, 20 Aug 2024 20:35:00 GMT', 'description': 'Merck & Co. Inc. stock outperforms competitors on strong trading day  MarketWatch', 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?", 'publisher': {'href': 'https://simplywall.st', 'title': 'Simply Wall St'}, 'created_at': 'Tue, 20 Aug 2024 16:25:22 GMT', 'description': "Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?  Simply Wall St", 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Merck & Co's Options: A Look at What the Big Money is Thinking", 'publisher': {'href': 'https://www.benzinga.com', 'title': 'Benzinga'}, 'created_at': 'Mon, 19 Aug 2024 20:00:32 GMT', 'description': "Merck & Co's Options: A Look at What the Big Money is Thinking  Benzinga", 'url': 'https://news.google.com/rss/articles/CBMitgFBVV95cUxPdjE4NVlubEMxZno3Yi1pWVhhc2JhbzdzVHpaZ1h4ckJvQkZMblpmRmZWQUZxamRPZmNQZGVZV0xBZkl6RmlPSkdpUEotbTZReVptVUtWOEU0MzJUbGloX2loNG1OeW9rLTNuSTNrOG1Uc2JwWDdNb1lNZkxxNDlBM21fRUJ2UXVNUlQySHdDdmhPaVcxalA3V09UM1Z0SllFalNrQVUxdXY5dkNhU1BPYnpRZkItQQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Our Q2 2024 sales and earnings report', 'publisher': {'href': 'https://www.merck.com', 'title': 'Merck'}, 'created_at': 'Tue, 30 Jul 2024 07:00:00 GMT', 'description': 'Our Q2 2024 sales and earnings report  Merck', 'url': 'https://news.google.com/rss/articles/CBMid0FVX3lxTE1qMFg1RW5HN1BvN0hIX0E0a25OeUk5UHlUQng2aGE4UkVacHUxQTBFc3RjTERiR2FnR1hpcHFWRVJBQUtWNUhpWEJUcE5ZSEJBZ0QtSDNNNVdiNHkwLVdMWG84aDRDRWJORDV1X2FnY3I4MXRIZHA4?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Merck & Co. Inc. stock rises Monday, still underperforms market', 'publisher': {'href': 'https://www.marketwatch.com', 'title': 'MarketWatch'}, 'created_at': 'Mon, 19 Aug 2024 20:35:00 GMT', 'description': 'Merck & Co. Inc. stock rises Monday, still underperforms market  MarketWatch', 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'A new foundation for future talent', 'publisher': {'href': 'https://www.merck.com', 'title': 'Merck'}, 'created_at': 'Mon, 22 Apr 2024 07:00:00 GMT', 'description': 'A new foundation for future talent  Merck', 'url': 'https://news.google.com/rss/articles/CBMic0FVX3lxTE1GUzE5dExlX213UnBoTnd0YldlLUJyYXZKQ3VYaFhlY0xER3ZmY2VnM29DOUc4ZzFoS1hCaEthSGljWHA5SWNpdkhEYmdBa2NOdnlpLTdPNDF5X3piT0VOdWo0Ri1QcjlaMGI3SWNlSmxSLW8?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing", 'publisher': {'href': 'https://www.fiercepharma.com', 'title': 'FiercePharma'}, 'created_at': 'Fri, 16 Aug 2024 12:59:00 GMT', 'description': "Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing  FiercePharma", 'url': 'https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMmtEUkkwdEVaX1NTQS12VEpHR0lmczNKdlFSSUdBS25WaXNId0xDY25TQi0weTc4dXVfZFlnbDZILXBHVWhUQS12RE5zb3RZWnlmN1pWZ19sMGRLbHhkUFg1TnRaQTR3REoyZWFNNFR4ZTFJMllfNUJLa3Nsam9Hb19tdmUwVWw2ZFY4ZG1BUjUzWkRjejc4V1dnTTdQSVFXOGU5Z3NiSWNLeHZsVU4yR1dySkh3VFFBRklz?oc=5&hl=en-US&gl=US&ceid=US:en'}
